Financhill
Back

Trevi Therapeutics Stock Price Chart

  • Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and TRVI is experiencing buying pressure, which is a positive indicator for future bullish movement.

Trevi Therapeutics Price Chart Indicators

Moving Averages Level Buy or Sell
8-day SMA: 6.47 Buy
20-day SMA: 6.54 Sell
50-day SMA: 6.29 Buy
200-day SMA: 4.13 Buy
8-day EMA: 6.46 Buy
20-day EMA: 6.44 Buy
50-day EMA: 6.06 Buy
200-day EMA: 4.53 Buy

Trevi Therapeutics Technical Analysis Indicators

Chart Indicators Level Buy or Sell
MACD (12, 26): 0.09 Buy
Relative Strength Index (14 RSI): 52.86 Buy
Chaikin Money Flow: 579796 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (6.14 - 6.74) Buy
Bollinger Bands (100): (4.08 - 6.36) Buy

Trevi Therapeutics Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Technical Analysis for Trevi Therapeutics Stock

Is Trevi Therapeutics Stock a Buy?

TRVI Technical Analysis vs Fundamental Analysis

Buy
63
Trevi Therapeutics (TRVI) is a Buy

Is Trevi Therapeutics a Buy or a Sell?

Trevi Therapeutics Stock Info

Market Cap:
660.3M
Price in USD:
6.49
Share Volume:
773.1K

Trevi Therapeutics 52-Week Range

52-Week High:
7.39
52-Week Low:
2.30
Buy
63
Trevi Therapeutics (TRVI) is a Buy

Trevi Therapeutics Share Price Forecast

Is Trevi Therapeutics Stock a Buy?

  • Trevi Therapeutics share price is 6.49 while TRVI 8-day exponential moving average is 6.46, which is a Buy signal.
  • The stock price of TRVI is 6.49 while Trevi Therapeutics 20-day EMA is 6.44, which makes it a Buy.
  • Trevi Therapeutics 50-day exponential moving average is 6.06 while TRVI share price is 6.49, making it a Buy technically.
  • TRVI stock price is 6.49 and Trevi Therapeutics 200-day simple moving average is 4.53, creating a Buy signal.

Fundamental Analysis of Trevi Therapeutics

Is Trevi Therapeutics a good investment?

  • Analysts estimate an earnings increase this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.05 per share, and a decrease next year of $0.07 per share.

Technical Analysis of Trevi Therapeutics

Should I short Trevi Therapeutics stock?

* Trevi Therapeutics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.